The role of T cells in vascular aging, hypertension, and atherosclerosis.

Theodore M DeConne, David J Buckley, Daniel W Trott, Christopher R Martens

Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States.Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States. · pubmed

Paper

Abstract

Vascular dysfunction has emerged as a significant risk factor for the development of cardio- and cerebrovascular diseases (CVDs), which are currently the leading cause of morbidity and mortality worldwide. T lymphocytes (T cells) have been shown to be important modulators of vascular function in primary aging and CVDs, likely by producing inflammatory cytokines and reactive oxygen species that influence vasoprotective molecules. This review summarizes the role of T cells on vascular function in aging, hypertension, and atherosclerosis in animals and humans, and discusses potential T-cell targeted therapeutics to prevent, delay, or reverse vascular dysfunction.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper discusses the role of T cells in vascular aging and related diseases, which is pertinent to understanding mechanisms of aging and potential interventions. However, it primarily focuses on the modulation of vascular function rather than addressing the root causes of aging itself. The therapeutic implications mentioned are interesting but do not represent a significant advancement in the field of longevity research. Thus, while it is relevant, its impact is limited.

Author of this paper? Send a correction.